P10s-PADRE vaccine combined with neoadjuvant chemotherapy in ER-positive breast cancer patients induces humoral and cellular immune responses

Breast cancer patients diagnosed with HR+/HER2– tumors face a persistent risk of distant recurrence long after completion of their treatment. Strategies to induce anti-tumor immune responses could complement standard-of-care therapies for these patients. The current study was performed to examine th...

Descripción completa

Detalles Bibliográficos
Autores principales: Makhoul, Issam, Ibrahim, Saddam Mohammed, Abu-Rmaileh, Muhammad, Jousheghany, Fariba, Siegel, Eric R., Rogers, Lora J., Lee, John J., Pina-Oviedo, Sergio, Post, Ginell R., Beck, J. Thaddeus, Kieber-Emmons, Thomas, Monzavi-Karbassi, Behjatolah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8555684/
https://www.ncbi.nlm.nih.gov/pubmed/34733416
http://dx.doi.org/10.18632/oncotarget.28083

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8555684/
https://www.ncbi.nlm.nih.gov/pubmed/34733416
http://dx.doi.org/10.18632/oncotarget.28083

Ejemplares similares